Vicapsys Life Sciences, Inc. Research And Development Expense

Quick Answer

Vicapsys Life Sciences, Inc. reported Research And Development Expense of $15.3 thousand for the year ending 2023.

  • Vicapsys Life Sciences, Inc. showed an increase of +16.6% in Research And Development Expense from 2022 to 2023.
  • This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
  • XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2019 to 2023), Vicapsys Life Sciences, Inc.'s Research And Development Expense has declined by 84.6%.
  • Historical annual values: Fiscal year 2023: $15.3 thousand | Fiscal year 2022: $13.1 thousand | Fiscal year 2021: $17.7 thousand | Fiscal year 2020: $102.2 thousand | Fiscal year 2019: $99.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: